What you need to know about the latest draft guidance for manufactures regarding medication guides and the current scene of classwide REMs.
Specialty Pharmacy
Advertisement
Opposition to the Express Scripts-Medco merger stems from concerns over reduced access, increased prices, and diminished patient care.
Advertisement
Pharmacy Times publishes the third edition of this new journal with a special focus on oncology trends for the growing specialty pharmacy market.
What pharmacists need to know now about this standardization and how it affects the industry.
What each stakeholder needs to know about REMS in today's fast-paced climate.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
Researchers Target Viral Fusion for Universal Flu, HIV Vaccines
5